INTERNATIONAL PATENT: BOEHRINGER INGELHEIM INTERNATIONAL GMBH FILES APPLICATION FOR "MYELOID-DERIVED GROWTH FACTOR FOR USE IN TREATING OR PREVENTING A LIVER DISORDER"

GENEVA, March 10 -- BOEHRINGER INGELHEIM INTERNATIONAL GMBH (Binger Strasse 173, 55216 Ingelheim Am Rhein) filed a patent application (PCT/JP2024/080151) for "MYELOID-DERIVED GROWTH FACTOR FOR USE IN TREATING OR PREVENTING A LIVER DISORDER" on Aug 30, 2024. With publication no. WO/2025/047991, the details related to the patent application was published on Mar 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PEKCEC, Anton (c/o Boehringer Ingelheim International GmbH,Binger Strasse 173, 55216 Ingelheim Am Rhein), MAEDA, Tomoko (ThinkPark Tower, 2-1-1 Osaki, Shinagawa-ku, Tokyo1416090), HOND...